Skip to main content
Oria Health

Research Database

Compound Encyclopedia

Mechanism of action, clinical evidence, and safety profiles for research compounds.

AOD-9604 vial
01 / PeptideB

AOD-9604

Human growth hormone fragment · 15 amino acids

Phase II
BPC-157 vial
02 / PeptideB+

BPC-157

Body Protective Compound · 15 amino acids

Pre-clinical
CJC-1295 vial
03 / PeptideB

CJC-1295

Modified GHRH analogue · 29/44 amino acids

Phase I
DSIP vial
04 / PeptideC

DSIP

Delta sleep-inducing peptide · 9 amino acids

Pre-clinical
Epithalon vial
05 / PeptideC

Epithalon

Synthetic telomerase activator · 4 amino acids

Phase I
Ipamorelin vial
06 / PeptideB

Ipamorelin

Growth hormone secretagogue · 5 amino acids

Pre-clinical
Kisspeptin vial
07 / HormoneB

Kisspeptin

GnRH release regulator · 54 amino acids

Phase II
MK-677 vial
08 / PeptideB+

MK-677

Oral growth hormone secretagogue · non-peptide

Phase II
PT-141 vial
09 / HormoneB+

PT-141

Melanocortin receptor agonist · synthetic peptide

Approved
Retatrutide vial
10 / GLP-1B+

Retatrutide

Triple-acting incretin · 39 amino acids

Phase III
Selank vial
11 / NootropicB

Selank

Synthetic tuftsin analogue · 7 amino acids

Phase II
Semaglutide vial
12 / GLP-1A

Semaglutide

GLP-1 receptor agonist · 31 amino acids

Approved
Semax vial
13 / NootropicB

Semax

Synthetic ACTH fragment · 7 amino acids

Phase II
TB-500 vial
14 / RepairC

TB-500

Thymosin Beta-4 fragment · 43 amino acids

Pre-clinical
Tesamorelin vial
15 / HormoneA

Tesamorelin

Growth hormone-releasing hormone analogue · 44 amino acids

Approved
Adamax vial
16 / Peptide

Adamax

Adamantane-modified Semax · BDNF upregulator

Pre-clinicalAnalysis soon
Adipotide vial
17 / Peptide

Adipotide

Prohibitin-targeting peptide · synthetic peptidomimetic

Pre-clinicalAnalysis soon
Fragment 176-191 vial
18 / Peptide

Fragment 176-191

hGH lipolytic fragment · 16 amino acids

Pre-clinicalAnalysis soon
GHK-Cu vial
19 / Peptide

GHK-Cu

Copper peptide · tissue repair & collagen synthesis

Pre-clinical / CosmeticAnalysis soon
GHRP-2 vial
20 / Peptide

GHRP-2

Growth hormone-releasing peptide · 6 amino acids

Pre-clinicalAnalysis soon
GHRP-6 vial
21 / Peptide

GHRP-6

Growth hormone-releasing peptide · 6 amino acids

Pre-clinicalAnalysis soon
KPV vial
22 / Peptide

KPV

Alpha-MSH C-terminal fragment · NF-kB inhibitor

Pre-clinicalAnalysis soon
Melanotan II vial
23 / Peptide

Melanotan II

Melanocortin receptor agonist · synthetic peptide

Pre-clinicalAnalysis soon
MOTS-c vial
24 / Peptide

MOTS-c

Mitochondrial-derived peptide · 16 amino acids

Pre-clinicalAnalysis soon
Sermorelin vial
25 / Peptide

Sermorelin

GHRH(1–29) analog · pituitary GH secretagogue

Approved (pediatric)Analysis soon
SS-31 vial
26 / Peptide

SS-31

Elamipretide · mitochondrial cardiolipin stabilizer

Phase IIAnalysis soon
Thymalin vial
27 / Peptide

Thymalin

Thymus extract polypeptide · bioregulator

Phase IAnalysis soon
Tirzepatide vial
28 /

Tirzepatide

Dual GIP/GLP-1 agonist · Mounjaro / Zepbound

ApprovedAnalysis soon